Edition:
India

People: Aptinyx Inc (APTX.OQ)

APTX.OQ on NASDAQ Stock Exchange Global Select Market

4.10USD
10:34pm IST
Change (% chg)

$-0.05 (-1.20%)
Prev Close
$4.15
Open
$4.17
Day's High
$4.18
Day's Low
$4.05
Volume
2,744
Avg. Vol
28,979
52-wk High
$22.63
52-wk Low
$2.61

Kidd, Andrew 

Mr. Andrew Kidd is Chief Operating Officer of the Company. He has served as our Chief Commercial Officer since November 2017 and as our Chief Operating Officer as of March 2019. He was previously at Baxter International for over ten years, most recently as senior vice president of strategy and business development. Prior to that he held a number of commercial leadership positions including general manager of Baxter Canada, global franchise head for surgical care, and general manager of U.S. anesthesia and cardiovascular. Before joining Baxter he worked at The Boston Consulting Group both in London and then Chicago focused on pharmaceutical and other healthcare clients. Mr. Kidd received a BM BCh medical degree from the University of Oxford and a B.A. in medical sciences from the University of Cambridge.

Basic Compensation

Total Annual Compensation, USD 341,417
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 551,297
Fiscal Year Total, USD 892,714

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Wilbur Gantz

38,244

Norbert Riedel

1,873,190

Ashish Khanna

721,046

Andrew Kidd

892,714

Joseph Moskal

497,858

Patrick Enright

24,391
As Of  31 Dec 2018